AR and posterior cortical atrophy: In our study, we integrated over 1300 clinical samples with sequencing information, and we studied the profile of m5C regulators from a global multi-omics perspective to assess their overall relevance to PCa clinicopathological characteristics, molecular subtypes, prognosis, androgen receptor signaling inhibitor (ARSI) therapy benefits, and immune phenotypes to determine potential immunotherapy opportunities for PCa.